Stock listing
ALVAL Stock Price, News, Filings & Events — Valbiotis Sa
Selected listing: ALVAL · EURONEXT · EUR · FR
This page tracks Valbiotis Sa's ALVAL:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVAL:EURONEXT. ALVAL:EURONEXT is the stock-level entry point for investors researching Valbiotis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €32.07 million. The company focuses on the development of innovative solutions for the prevention and management of metabolic diseases. Valbiotis is committed to advancing research and delivering products that address significant health challenges.

- Ticker
- ALVAL:EURONEXT
- Asset type
- Stock
- Market cap
- $33.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- EURONEXT
- Currency
- EUR
Valbiotis Sa ALVAL:EURONEXT stock context
This page tracks Valbiotis Sa's ALVAL:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALVAL:EURONEXT. ALVAL:EURONEXT is the stock-level entry point for investors researching Valbiotis Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €32.07 million. The company focuses on the development of innovative solutions for the prevention and management of metabolic diseases. Valbiotis is committed to advancing research and delivering products that address significant health challenges.
Latest news from Valbiotis Sa
VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition f...
July 22, 2026
VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
June 26, 2026
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained PSR in the amount of €10.2M secured by commitments amo...
June 8, 2026
VALBIOTIS SA: Valbiotis continues its expansion in Asia
May 11, 2026
VALBIOTIS SA: Valbiotis expands its e-commerce to Belgium and Luxembourg
April 23, 2026
Research Valbiotis Sa
Valbiotis Sa investor report
Review AI stock analysis and investor report context for ALVAL:EURONEXT.
Valbiotis Sa company profile
View the public company page for Valbiotis Sa on 6ix.
Valbiotis Sa news
Read company news and market updates connected to Valbiotis Sa.
Valbiotis Sa investor events
Find investor webinars, events, and replay context for Valbiotis Sa.
Alternate listings
8JD:GETTEX
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
A2DS5F:LSX
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
A2DS5F:LS
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
8JD:FWB
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
8JD:DUS
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
8JD:MUN
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
8JD:SWB
DE · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.
ALVALP:TURQUOISE
GB · EUR
Alternate listing for Valbiotis Sa; the primary context on this page is ALVAL:EURONEXT.